RG 7351Alternative Names: RG7351
Latest Information Update: 25 Mar 2017
At a glance
- Originator Roche
- Class Antidepressants
- Mechanism of Action Trace amine-associated receptor 1 agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Major depressive disorder in Unknown
- 03 Feb 2010 Phase-I clinical trials in Depression (unspecified route)